24th Annual Biotech in Europe Forum, Basel - Rapid Advancements with New Targets and Modalities Panel

Our CEO Lynn Durham discusses rapid advancements in neurodevelopmental disorder treatment at the annual SACHS biotech meeting

Go to video

job-arrow